What is shared decision-making in healthcare?
Shared decision-making is a collaborative process that allows patients and their physicians to make healthcare treatment decisions together
The process considers the best scientific evidence available, as well as the patients' values and preferences1
Why is shared decision-making important?
The Centers for Medicare and Medicaid Services (CMS) encourages the use of an evidence-based tool in any physician and patient discussions to help document the appropriateness of left atrial appendage closure (LAAC) as a non-pharmacological treatment option in comparing the risk-benefit to anticoagulants.
- Patient-provider discussions may uncover barriers to change that include physical pain, emotional difficulties, financial concerns, and lack of confidence in one’s ability to change
- These and other barriers can then be addressed so that a realistic personal prevention plan is formulated with specific and achievable outcomes
How does shared decision-making work?
In clinical scenarios characterized by more than one viable treatment or screening option, providers facilitate shared decision-making by:
- Encouraging patients to communicate what they care about
- Providing decision aids that raise the patient’s awareness and understanding of treatment options and possible outcomes
Where does the SHARE approach come from?
Each step of the SHARE approach contributes to its success in evidence-based treatment decisions.2
What is the role of shared decision-making in LAAC procedures?
A formal shared decision-making interaction with an independent non-interventional physician using an evidence-based decision tool is recommended for patients with non-valvular atrial fibrillation (NVAF) prior to LAAC3
The shared decision-making interaction must also be documented in the medical record
The patient must be suitable for short-term warfarin but deemed unable to take long-term oral anticoagulation (OAC) following the conclusion of shared decision-making, as LAAC is only covered as a second-line therapy to OACs
Which patients are eligible for a WATCHMAN LAAC Implant?
Patients must meet the criteria for LAAC eligibility, and these criteria must be documented in the patient’s medical record.
Shared decision-making resources
The following resources will help you have more productive conversations with your patients about the risks and benefits of anticoagulation treatment for non-valvular atrial fibrillation.
View estimated patient costs
References:
1. Centers for Medicare & Medicaid Services. Decision memo for percutaneous left atrial appendage (LAA) closure therapy (CAG-00445N). https://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=281&ExpandComments=n&DocID=CAG-00445N&bc=gAAAAAgAAgAAAA%3d%3d&. Published February 8, 2016. Accessed May 20, 2016.
2. Agency for Healthcare Research and Quality. U.S. Department of Health & Human Services. http://www.ahrq.gov/professionals/education/curriculum-tools/shareddecisionmaking/index.html. Accessed May 20, 2016.
3. Barry MJ, Edgman-Levitan S. Shared decision making—the pinnacle of patient-centered care. N Engl J Med. 2012;366(9):780-781.